Cyclerion Therapeutics, Inc. (CYCN)

Cyclerion Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2.82	3.24	3.23	7.57	13.38	53.96
Cash & Short-Term Investments	2.82	3.24	3.23	7.57	13.38	53.96
Cash Growth	-22.42%	0.25%	-57.31%	-43.42%	-75.20%	-0.80%
Accounts Receivable	-	1	0.56	-	0.1	0.1
Other Current Assets	0.27	0.4	0.44	0.45	1.34	1.4
Total Current Assets	3.09	4.64	4.23	8.02	14.82	55.46
Net Property, Plant & Equipment	0.07	-	-	-	1.22	1.47
Long-Term Investments	5.35	5.35	5.35	5.35	-	-
Other Long-Term Assets	-	-	-	-	2.04	2.41
Total Assets	8.51	9.99	9.58	13.37	18.08	59.33
Accounts Payable	0.46	0.51	0.39	1.2	2.97	1.83
Accrued Expenses	1.26	0.39	0.34	0.89	4.66	9.26
Total Current Liabilities	1.71	0.9	0.73	2.09	7.63	11.09
Total Liabilities	1.71	0.9	0.73	2.09	7.63	11.09
Additional Paid-in Capital	280.99	280.11	276.34	275.72	269.63	263.35
Accumulated Other Comprehensive Income	-	-	-	-0.01	-0.02	-0.02
Retained Earnings	-274.2	-271.02	-267.49	-264.42	-259.15	-215.08
Shareholders' Equity	6.79	9.09	8.85	11.29	10.45	48.25
Total Liabilities & Equity	8.51	9.99	9.58	13.37	18.08	59.33
Net Cash (Debt)	2.82	3.24	3.23	7.57	13.38	53.96
Net Cash Growth	-22.42%	0.25%	-57.31%	-43.42%	-75.20%	523.11%
Net Cash Per Share	0.56	1.02	1.28	3.24	6.16	27.57
Book Value	6.79	9.09	8.85	11.29	10.45	48.25
Book Value Per Share	1.36	2.86	3.51	4.83	4.81	24.65
Tangible Book Value	6.79	9.09	8.85	11.29	10.45	48.25
Tangible Book Value Per Share	1.36	2.86	3.51	4.83	4.81	24.65

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 12, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 4, 2026

Data Sources Report a data error